Combining fiber and metformin to treat obesity and insulin resistance in teens
Official title: Fiber Supplementation and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance: Interactions With the Gut Microbiome.
Run by University of Alberta · NCT04578652 · Data updated 2026-11-12
This study is testing whether adding fiber to the diabetes drug metformin can help teens aged 12-18 with severe obesity and insulin resistance improve their health over a year.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 12 Years to 18 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | University of Alberta Academic / other |
| Locations | 1 site (Edmonton, Alberta) |
| Status | Recruiting |
| Started | October 22, 2021 |
| Main results expected | February 2027 |
| Study ends | February 2027 |
| Registry record updated | October 23, 2026 |
| Trial ID | NCT04578652 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 12-18 with a BMI above the 95th percentile and a family history of type 2 diabetes.
✕Probably not a fit
Patients currently using insulin or diagnosed with type 2 diabetes will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of dietary fiber and metformin, both separately and in combination, on adolescents aged 12-18 with severe obesity and insulin resistance over a 12-month period. The study employs a double-blind, randomized, three-arm parallel design to assess changes in glucose metabolism, inflammation, and body mass index (BMI). Additionally, it aims to explore how these interventions may influence gut microbiome composition and function. The hypothesis is that the combination of fiber and metformin will yield greater improvements in metabolic function compared to either treatment alone.
Why it matters
Potential benefit: If successful, this approach could significantly improve metabolic health and weight management in adolescents with obesity and insulin resistance.
How similar studies have gone: Previous studies have shown positive outcomes with similar dietary and pharmacological interventions, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 12-18 years 2. BMI percentile \> 95% for age/sex; 3. Total weight fluctuation over past 6 months \< 10%; 4. HOMA-IR \> 3.16; 5. FH of T2DM (first or second-degree relative). Exclusion Criteria: 1. Current use of insulin or diagnosis of T2DM; 2. Systolic or diastolic blood pressure (BP) \> 99th percentile for age and sex; 3. Acute infectious or inflammatory condition over the preceding 1 month; hospitalization \> 48 hrs; 4. History of chronic disease such as inflammatory bowel disease, chronic severe liver or kidney disease or neurologic disorders; 5. Active malignancy; 6. Concomitant use of medication/investigational drug known to affect body weight in the past year; 7. Antibiotic use in past 60 days; probiotic and/or prebiotic supplements use in the past 30 days; use of lipid-lowering and anti-inflammatory medication.
Where it's running
-
University of Alberta
Edmonton, Alberta, Canada Recruiting
Study contacts
- Principal investigator: Andrea M Haqq, MD, MHS — University of Alberta
- Study coordinator: Andrea M Haqq, MD, MHS
- Email: haqq@ualberta.ca
- Phone: 780-492-0015
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Vitamin D supplementation for obese children
This study is testing whether different doses of vitamin D can help obese kids and teens improve their insulin levels and body fat over six months.
-
Investigating brain health in youth at risk for type 2 diabetes
This study is trying to see how being overweight or having blood sugar issues affects brain health in kids aged 12-17 who might be at risk for type 2 diabetes.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Wise Interventions to Boost Pediatric Weight Control
This study tests whether adding two quick social-psychology activities (growth mindset and self-affirmation) to a family-based weight management program helps 10–15 year-olds with obesity achieve better BMI outcomes over 12 months.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Alpelisib Challenge Test to measure insulin secretory capacity
Researchers will test a new approach to measure how much insulin the body can produce in people at various weights and with or without insulin resistance, using alpelisib around a meal test.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.